Literature DB >> 7834891

Associations of genotypes at the apolipoprotein AI-CIII-AIV, apolipoprotein B and lipoprotein lipase gene loci with coronary atherosclerosis and high density lipoprotein subclasses.

R E Peacock1, A Hamsten, J Johansson, P Nilsson-Ehle, S E Humphries.   

Abstract

Association studies were carried out in a sample of 86 patients from Sweden who had survived a myocardial infarction (MI) at a young age and 93 age-matched healthy individuals, to compare the impact of polymorphisms at the apolipoprotein (apo) AI-CIII-AIV gene cluster on among-individual differences in plasma lipid and lipoprotein traits, the five high density lipoprotein (HDL) subclasses (2b to 3c), lipoprotein lipase (LPL) activity and presence and progression of atherosclerosis. Individuals were genotyped for four polymorphisms; 5'apoAI (G/A-75), 3'apoAI (PstI; P +/-), apoCIII (C/T1100) and apoCIII (PvuII; V +/-), using PCR-based techniques. Allele frequencies were similar in healthy individuals and patients (frequencies of alleles in combined population: 5'apoAI-A-75 = 0.14, 3'apoAI-P- = 0.05, apoCIII-T1100 = 0.27 and apoCIII-V- = 0.18). In the healthy individuals, levels of low density lipoprotein (LDL) triglycerides were significantly associated with genotypes of the apoCIII-PvuII polymorphism (p = 0.02), but no other associations were found between lipids or HDL subclasses and single polymorphisms in the apoAI-CIII-AIV gene cluster. Levels of triglycerides and very low density lipoprotein (VLDL) triglycerides were significantly higher in the presence of the haplotype defined by the presence of apoCIII-T1100 and common alleles of the other three polymorphisms, explaining 5.8% and 7.8% (p = 0.03 and 0.01), respectively, of sample variance. In the patients, no associations were found between lipids or HDL subclasses and variation at the apoAI-CIII-AIV gene cluster. Associations were also examined between levels of HDL subclasses and variation at the apoE (common isoforms), apoB (signal peptide and XbaI polymorphisms) and lipoprotein lipase (PvuII, HindIII and Serine447/Stop polymorphisms) gene loci. In the patient group only, levels of protein in HDL2b, HDL2a and HDL3b subclasses were significantly associated with genotypes of the LPL-HindIII polymorphism (22.1, 19.3 and 11.4%, respectively, of sample variance; p < 0.05). Finally, associations were examined between genotypes at the apoAI-CIII-AIV gene cluster and the extent of coronary atherosclerosis. Global severity of atherosclerosis at the first angiography was weakly associated with genotypes of the apoCIII-C/T1100 polymorphism, presence of the T1100 allele being associated with 53% lower median score (1.6 vs 0.75; p = 0.09).(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7834891     DOI: 10.1111/j.1399-0004.1994.tb04159.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  8 in total

1.  The effects of scale: variation in the APOA1/C3/A4/A5 gene cluster.

Authors:  Stephanie M Fullerton; Anne V Buchanan; Vibhor A Sonpar; Scott L Taylor; Joshua D Smith; Christopher S Carlson; Veikko Salomaa; Jari H Stengård; Eric Boerwinkle; Andrew G Clark; Deborah A Nickerson; Kenneth M Weiss
Journal:  Hum Genet       Date:  2004-04-24       Impact factor: 4.132

2.  Regression-based association analysis with clustered haplotypes through use of genotypes.

Authors:  Jung-Ying Tzeng; Chih-Hao Wang; Jau-Tsuen Kao; Chuhsing Kate Hsiao
Journal:  Am J Hum Genet       Date:  2005-12-19       Impact factor: 11.025

3.  Evidence of linkage of familial hypoalphalipoproteinemia to a novel locus on chromosome 11q23.

Authors:  E N Kort; D G Ballinger; W Ding; S C Hunt; B R Bowen; V Abkevich; K Bulka; B Campbell; C Capener; A Gutin; K Harshman; M McDermott; T Thorne; H Wang; B Wardell; J Wong; P N Hopkins; M Skolnick; M Samuels
Journal:  Am J Hum Genet       Date:  2000-04-17       Impact factor: 11.025

4.  APOA1/A5 variants and haplotypes as a risk factor for obesity and better lipid profiles in a Brazilian Elderly Cohort.

Authors:  Elizabeth Suchi Chen; Tatiane Katsue Furuya; Diego Robles Mazzotti; Vanessa Kiyomi Ota; Maysa Seabra Cendoroglo; Luiz Roberto Ramos; Lara Quirino Araujo; Rommel Rodriguez Burbano; Marília de Arruda Cardoso Smith
Journal:  Lipids       Date:  2010-05-18       Impact factor: 1.880

5.  Monogenic causes of elevated HDL cholesterol and implications for development of new therapeutics.

Authors:  Daniel B Larach; Marina Cuchel; Daniel J Rader
Journal:  Clin Lipidol       Date:  2013-12

6.  Population-Based Resequencing of LIPG and ZNF202 Genes in Subjects with Extreme HDL Levels.

Authors:  Hamid Razzaghi; Stephanie A Santorico; M Ilyas Kamboh
Journal:  Front Genet       Date:  2012-06-14       Impact factor: 4.599

Review 7.  The roles of genetic polymorphisms and human immunodeficiency virus infection in lipid metabolism.

Authors:  Elaine Regina Delicato de Almeida; Edna Maria Vissoci Reiche; Ana Paula Kallaur; Tamires Flauzino; Maria Angelica Ehara Watanabe
Journal:  Biomed Res Int       Date:  2013-11-12       Impact factor: 3.411

8.  Apolipoprotein Gene Polymorphisms (APOB, APOC111, APOE) in the Development of Coronary Heart Disease in Ethnic Groups of Kazakhstan.

Authors:  S Berkinbayev; M Rysuly; A Mussayev; K Blum; N Baitasova; A Mussagaliyeva; G Dzhunusbekova; B Makhatov; Aa Mussayev; A Yeshmanova; R Lesbekova; Y Marchuk; R Azhibekova; M Oscar-Berman; M Kulmaganbetov
Journal:  J Genet Syndr Gene Ther       Date:  2014-01-24
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.